je.st
news
Tag: gilead
Gilead Prices $4 Billion of Senior Unsecured Notes
2014-11-13 02:13:07| Biotech - Topix.net
FOSTER CITY, Calif.-- -- Gilead Sciences, Inc. today announced the pricing of senior unsecured notes in an aggregate principal amount of $4 billion, in an underwritten, registered public offering, consisting of three tranches: The senior notes are rated A- by Standard & Poor's and A3 by Moody's. The offering is expected to close November 17, 2014, subject to customary closing conditions.
Tags: prices
notes
senior
billion
Gilead: Another Competitor Bites The Dust
2014-11-12 04:58:35| Biotech - Topix.net
Despite a very successful 2014 that included an almost quadrupling of earnings, investors remain overly pessimistic on the prospects of Gilead Sciences. The stock is cheap, competitors continue to fail to make inroads into its core hepatitis C franchise and sales there are just getting started and should continue to beat expectations.
Tags: dust
bites
competitor
gilead
Gilead: Still 40% Upside Ahead
2014-11-01 01:19:34| Biotech - Topix.net
As an unadulterated bull on Gilead Sciences, I have been inundated with emails requesting comments since the sales for Sovaldi "disappointed" on Tuesday. My outlook remains unaltered by these latest results.
Jim Cramer: Celgene, Gilead Leading Biotech Charge Higher
2014-10-25 17:46:08| Biotech - Topix.net
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Tags: higher
charge
leading
jim
Gilead Sciences Inc. moving to new site in La Verne
2014-09-28 08:21:43| Biotech - Topix.net
Gilead Sciences Inc., a major pharmaceutical company, will establish a 23-acre campus in La Verne that will employ 500 people, extend Wheeler Avenue to Puddingstone Drive and conduct research for cures and improved treatment techniques for significant diseases. The scientific and medical research company committed to advancing therapeutics which improve lives will relocate from San Dimas to La Verne and take over a 23-acre parcel in the industrial and manufacturing zone in La Verne's southern quadrant, noted La Verne Senior Planner Eric Scherer during a recent La Verne City Council meeting.
Sites : [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] next »